
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Methyltransferase-like 3 mediates m6A modification of heme oxygenase 1 mRNA to induce ferroptosis of renal tubular epithelial cells in acute kidney injury
Linxiao Lv, Mingyang Hu, Jiacheng Li, et al.
Free Radical Biology and Medicine (2025)
Open Access
Linxiao Lv, Mingyang Hu, Jiacheng Li, et al.
Free Radical Biology and Medicine (2025)
Open Access
m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Nanozyme-Based Strategies in Cancer Immunotherapy: Overcoming Resistance to Enhance Therapeutic Efficacy
Guangjian Hou, Yukun Xu, Chunhua Wang, et al.
Aging and Disease (2025)
Open Access
Guangjian Hou, Yukun Xu, Chunhua Wang, et al.
Aging and Disease (2025)
Open Access
Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access
RNA Modification in Metabolism
Yadi Liu, Zhongyan Sun, Dingkun Gui, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Yadi Liu, Zhongyan Sun, Dingkun Gui, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
m5C methylation of mitochondrial RNA and non-coding RNA by NSUN3 is associated with variant gene expression and asexual blood-stage development in Plasmodium falciparum
Ruoyu Tang, Xuan Chen, Xiaomin Shang, et al.
Parasites & Vectors (2025) Vol. 18, Iss. 1
Open Access
Ruoyu Tang, Xuan Chen, Xiaomin Shang, et al.
Parasites & Vectors (2025) Vol. 18, Iss. 1
Open Access
Circular RNA in liver cancer research: biogenesis, functions, and roles
Jia‐Yi Wang, Congcong Zhang, Yinghui Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jia‐Yi Wang, Congcong Zhang, Yinghui Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
PCIF1 drives oesophageal squamous cell carcinoma progression via m6Am‐mediated suppression of MTF2 translation
Kang Li, Yi Yang, Rongsong Ling, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Kang Li, Yi Yang, Rongsong Ling, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
5-Methylcytosine RNA modification and its roles in cancer and cancer chemotherapy resistance
Li Fang, Tingting Liu, Yi Dong, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Li Fang, Tingting Liu, Yi Dong, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Analysis of human brain RNA-seq data reveals combined effects of 4 types of RNA modifications and 18 types of programmed cell death on Alzheimer’s disease
Ke Ye, Xinyu Han, Maoyi Tian, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Ke Ye, Xinyu Han, Maoyi Tian, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Dynamic rRNA modifications as a source of ribosome heterogeneity
Ivan Milenkovic, Eva Maria Novoa
Trends in Cell Biology (2024)
Closed Access | Times Cited: 2
Ivan Milenkovic, Eva Maria Novoa
Trends in Cell Biology (2024)
Closed Access | Times Cited: 2
INTERPLAY BETWEEN EPIGENETICS, SENESCENCE AND CELLULAR REDOX METABOLISM IN CANCER AND ITS THERAPEUTIC IMPLICATIONS
Geoffrey Balamurli, Angeline Qiu Xia Liew, Wee‐Wei Tee, et al.
Redox Biology (2024) Vol. 78, pp. 103441-103441
Open Access | Times Cited: 1
Geoffrey Balamurli, Angeline Qiu Xia Liew, Wee‐Wei Tee, et al.
Redox Biology (2024) Vol. 78, pp. 103441-103441
Open Access | Times Cited: 1
5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis
Chuan-Jian Shi, Fengxiang Pang, Yuhe Lei, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101181-101181
Open Access | Times Cited: 1
Chuan-Jian Shi, Fengxiang Pang, Yuhe Lei, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101181-101181
Open Access | Times Cited: 1
FUS and METTL3 collaborate to regulate RNA maturation, preventing unfolded protein response and promoting gastric cancer progression
Dongtao Liu, Bo Ding, Gang Liu, et al.
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access
Dongtao Liu, Bo Ding, Gang Liu, et al.
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access